RXST
Price
$5.08
Change
+$0.18 (+3.67%)
Updated
Oct 22 closing price
Capitalization
211.29M
12 days until earnings call
Intraday BUY SELL Signals
STE
Price
$232.18
Change
+$10.70 (+4.83%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
21.59B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RXST vs STE

RXST vs STE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
RXST vs. STE commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXST is a StrongBuy and STE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for RXST with price predictions
Oct 22, 2026

RXST's RSI Indicator ascends from oversold territory

The RSI Oscillator for RXST moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 44 similar instances when the indicator left oversold territory. In 38 of the 44 cases the stock moved higher. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on RXST as a result. In 68 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

The Moving Average Convergence Divergence (MACD) for RXST just turned positive on October 07, 2026. Looking at past instances where RXST's MACD turned positive, the stock continued to rise in 39 of 47 cases over the following month. The odds of a continued upward trend are 83%.

Following a +4.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where RXST advanced for three days, in 234 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for RXST crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

RXST broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RXST entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.802) is normal, around the industry mean (2.874). P/E Ratio (-4.456) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.749) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. RXST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for STE with price predictions
Oct 22, 2026

STE in upward trend: price rose above 50-day moving average on October 15, 2026

STE moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 44 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 57%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on STE as a result. In 47 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.

The Moving Average Convergence Divergence (MACD) for STE just turned positive on September 29, 2026. Looking at past instances where STE's MACD turned positive, the stock continued to rise in 20 of 46 cases over the following month. The odds of a continued upward trend are 43%.

The 10-day moving average for STE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 41%.

Following a +3.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where STE advanced for three days, in 152 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.

The Aroon Indicator entered an Uptrend today. In 98 of 200 cases where STE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

STE broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. STE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.996) is normal, around the industry mean (2.874). P/E Ratio (26.944) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.760) is also within normal values, averaging (11.052). Dividend Yield (0.012) settles around the average of (0.009) among similar stocks. P/S Ratio (3.423) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

FUNDAMENTALS RATINGS
STE: Fundamental Ratings
STE
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
66
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RXSTSTE
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
62%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
63%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
49%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
43%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
52%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 11 days ago
48%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 4 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
58%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
49%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (RXST: $5.08 vs. STE: $221.48)
Brand notoriety: RXST and STE are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: RXST: 50% vs. STE: 274%
Market capitalization -- RXST: $211.29M vs. STE: $21.59B
RXST [@Medical/Nursing Services] is valued at $211.29M. STE’s [@Medical/Nursing Services] market capitalization is $21.59B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXST’s FA Score shows that 2 FA rating(s) are green while STE’s FA Score has 0 green FA rating(s).

  • RXST’s FA Score: 2 green, 3 red.
  • STE’s FA Score: 0 green, 5 red.
According to our system of comparison, RXST is a better buy in the long-term than STE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXST’s TA Score shows that 4 TA indicator(s) are bullish while STE’s TA Score has 5 bullish TA indicator(s).

  • RXST’s TA Score: 4 bullish, 5 bearish.
  • STE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both RXST and STE are a bad buy in the short-term.

Price Growth

RXST (@Medical/Nursing Services) experienced а +8.78% price change this week, while STE (@Medical/Nursing Services) price change was +1.94% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.50%. For the same industry, the average monthly price growth was -10.64%, and the average quarterly price growth was -10.25%.

Reported Earning Dates

RXST is expected to report earnings on Nov 03, 2026.

STE is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
RXST
Daily Signal:
Gain/Loss:
STE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

RXST and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXST has been loosely correlated with GMED. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RXST jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXST
1D Price
Change %
RXST100%
+3.67%
GMED - RXST
37%
Loosely correlated
+3.79%
DCTH - RXST
32%
Poorly correlated
+0.34%
STE - RXST
31%
Poorly correlated
+4.85%
AZTA - RXST
28%
Poorly correlated
-2.04%
LUNG - RXST
28%
Poorly correlated
+2.73%
More

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with SYK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
+4.85%
SYK - STE
53%
Loosely correlated
+3.19%
MDT - STE
52%
Loosely correlated
+3.83%
LH - STE
50%
Loosely correlated
+1.91%
GEHC - STE
50%
Loosely correlated
+3.49%
DHR - STE
49%
Loosely correlated
-1.76%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BSCR19.53N/A
N/A
Invesco BulletShares 2027 Corporate Bond ETF (BSCR)
MAXJ29.55-0.08
-0.27%
iShares Large Cap Max Buffer Jun ETF (MAXJ)
TXUE34.75-0.10
-0.28%
Thornburg International Equity ETF (TXUE)
SOFX5.95-0.11
-1.82%
Defiance Daily Target 2X Long SOFI ETF (SOFX)
EZMO25.65-0.63
-2.39%
AlphaDroid Broad Markets Momentum ETF (EZMO)